Solara Active Pharma Sciences sells 100% stake in SeQuent Penems

26 Apr 2024 Evaluate

Solara Active Pharma Sciences has completed sale of 100% shareholding in SeQuent Penems to M/s. Symbio Generrics India on April 25, 2024. Hence, SeQuent Penems ceased to be a subsidiary of the Company. The board of directors of the company at its meeting held on March 25, 2024 approved the same.  

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

492.00 -4.00 (-0.81%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.